BraVRy: VR Exposure Therapy for Anxiety Disorders

Step into a world of well-being. Welcome to BraVRy, where innovation meets empathy for a personalized journey to anxiety care.
BraVRy's framework flowchart seamlessly integrates VR simulations and biotracking data for personalized anxiety care.
BraVRy's intuitive dashboard – where immersive VR simulations meet advanced biotracking for personalized anxiety care.

BraVRy presents an innovative solution aimed at revolutionizing the treatment of specific phobias and PTSD by integrating cutting-edge VR technology with comprehensive biotracking.

Specific phobias afflict nearly 10% of Canadian adults, rivaling the prevalence of age-related hearing loss. The burden of anxiety disorders collectively surpasses that of cancer, highlighting the pressing need for advanced interventions.

Utilizing state-of-the-art VR simulations inspired by the effectiveness of exposure therapy, BraVRy harmonizes a comprehensive spectrum of biotracking data—comprising heart rate, blood pressure, breathing, brain activity, and body movement—through an accelerometer and gyroscope. This array of parameters offers a tangible understanding of anxiety levels, fostering personalized treatment approaches.

The platform's technical complexity is demonstrated through a customizable doctor's office within the VR space, facilitating diverse and adaptable experiences for patients. A dashboard visually tracks and analyzes biometric measures over treatment courses, enhancing clinicians' insights into patient progress.

BraVRy embodies creativity and innovation by seamlessly synthesizing biological measures with immersive technology, representing a breakthrough in comprehending and addressing anxiety disorders. This approach aligns with the superiority of VR exposure therapies in treating phobias and PTSD as shown in scientific literature, promising a paradigm shift in anxiety disorder treatment.

Considering commercial viability, BraVRy seeks to alleviate the economic burden of current anxiety disorder treatments, which cost Canada’s healthcare system over $6.8 billion in 2022, while significantly enhancing patient outcomes. Its impact is profound, ushering in a new era of treatment for anxiety disorders.

Welcome to BraVRy: where technology and empathy converge to transform mental health care.